Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
HBI
|
Joseph W Cavaliere
President, Innerwear - Global |
SELL
Payment of exercise price or tax liability
|
Direct | 23,677 Reduced 2.56% |
$139,694
$5.9 p/Share
|
Mar 27
2025 |
|
HBI
|
Michael E. Faircloth |
SELL
Payment of exercise price or tax liability
|
Direct | 14,873 Reduced 1.7% |
$87,750
$5.9 p/Share
|
Mar 27
2025 |
|
HBI
|
Markland Scott Lewis |
SELL
Payment of exercise price or tax liability
|
Direct | 16,143 Reduced 2.71% |
$95,243
$5.9 p/Share
|
Mar 27
2025 |
|
BSY
|
Brock Ballard
Chief Revenue Officer |
BUY
Grant, award, or other acquisition
|
Direct | 82 Added 0.1% |
-
|
Mar 27
2025 |
|
RLAY
|
Peter Rahmer |
SELL
Open market or private sale
|
Direct | 247 Reduced 0.06% |
$701
$2.84 p/Share
|
Mar 27
2025 |
|
BSY
|
Barry J. Bentley
Director |
BUY
Grant, award, or other acquisition
|
Direct | 5 Added 0.0% |
-
|
Mar 27
2025 |
|
FL
|
Michael Baughn
EVP & Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 4,531 Reduced 3.72% |
$69,188
$15.27 p/Share
|
Mar 27
2025 |
|
BSY
|
Gregory S Bentley
Executive Chair & President |
BUY
Grant, award, or other acquisition
|
Direct | 4,050 Added 0.05% |
-
|
Mar 27
2025 |
|
BSY
|
Keith A. Bentley
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,302 Added 0.03% |
-
|
Mar 27
2025 |
|
BSY
|
Raymond B. Bentley
Director |
BUY
Grant, award, or other acquisition
|
Direct | 1,754 Added 0.01% |
-
|
Mar 27
2025 |
|
UBX
|
Alexander Hieu Nguyen
CLO and Head of Ops |
SELL
Open market or private sale
|
Direct | 1,954 Reduced 7.96% |
$2,266
$1.16 p/Share
|
Mar 27
2025 |
|
BSY
|
Nicholas Cumins
Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct | 497 Added 0.11% |
-
|
Mar 27
2025 |
|
RLAY
|
Donald A Bergstrom
President, R&D |
SELL
Open market or private sale
|
Direct | 986 Reduced 0.16% |
$2,800
$2.84 p/Share
|
Mar 27
2025 |
|
FL
|
Jennifer Kraft
EVP and General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct | 1,667 Reduced 3.26% |
$25,455
$15.27 p/Share
|
Mar 27
2025 |
|
FL
|
Giovanna Cipriano
SVP & Chief Accounting Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 2,313 Reduced 2.4% |
$35,319
$15.27 p/Share
|
Mar 27
2025 |
|
RLAY
|
Brian Adams
Chief Legal Officer |
SELL
Open market or private sale
|
Direct | 298 Reduced 0.07% |
$846
$2.84 p/Share
|
Mar 27
2025 |
|
RLAY
|
Thomas Catinazzo
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 4,864 Reduced 1.28% |
$13,813
$2.84 p/Share
|
Mar 27
2025 |
|
EZFL
|
Michael D Farkas
CEO and Executive Chairman |
BUY
Other acquisition or disposition
|
Indirect | 32,372 Added 0.0% |
$89,346
$2.76 p/Share
|
Mar 27
2025 |
|
KSS
|
Siobhan Mc Feeney
Sr EVP & Chief Tech & Digi Off |
BUY
Grant, award, or other acquisition
|
Direct | 1,098 Added 0.83% |
-
|
Mar 27
2025 |
|
KSS
|
Siobhan Mc Feeney
Sr EVP & Chief Tech & Digi Off |
SELL
Payment of exercise price or tax liability
|
Direct | 3,892 Reduced 2.94% |
$34,833
$8.95 p/Share
|
Mar 27
2025 |
|
KSS
|
Christie Raymond
Sr. EVP & Chief Marketing Off. |
BUY
Grant, award, or other acquisition
|
Direct | 1,098 Added 0.59% |
-
|
Mar 27
2025 |
|
KSS
|
Christie Raymond
Sr. EVP & Chief Marketing Off. |
SELL
Payment of exercise price or tax liability
|
Direct | 3,766 Reduced 2.01% |
$33,705
$8.95 p/Share
|
Mar 27
2025 |
|
FL
|
Elliott Rodgers
EVP, Chief Operations Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 4,538 Reduced 3.84% |
$69,295
$15.27 p/Share
|
Mar 27
2025 |
|
KSS
|
Jill Timm
Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 3,645 Reduced 1.45% |
$32,622
$8.95 p/Share
|
Mar 27
2025 |
|
KSS
|
Jill Timm
Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct | 1,709 Added 0.67% |
-
|
Mar 27
2025 |
|
LSAK
|
Ali Mazanderani
Executive Chairman |
BUY
Open market or private purchase
|
Direct | 30,930 Added 6.18% |
$154,650
$5.0 p/Share
|
Mar 27
2025 |
|
WW
|
Tara Comonte
President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 36,035 Reduced 8.63% |
$19,458
$0.54 p/Share
|
Mar 27
2025 |
|
WW
|
Tara Comonte
President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 99,956 Added 19.31% |
-
|
Mar 27
2025 |
|
KSS
|
Nicholas David George Jones
Chief Merchandising Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 3,507 Reduced 5.57% |
$31,387
$8.95 p/Share
|
Mar 27
2025 |
|
KSS
|
Nicholas David George Jones
Chief Merchandising Officer |
BUY
Grant, award, or other acquisition
|
Direct | 1,627 Added 2.52% |
-
|
Mar 27
2025 |
|
FL
|
Mary N Dillon
CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 16,115 Reduced 2.96% |
$246,076
$15.27 p/Share
|
Mar 27
2025 |
|
KSS
|
Jennifer J. Kent
Sr.EVP & CLO & Corp. Sec. |
SELL
Payment of exercise price or tax liability
|
Direct | 2,344 Reduced 1.76% |
$20,978
$8.95 p/Share
|
Mar 27
2025 |
|
KSS
|
Jennifer J. Kent
Sr.EVP & CLO & Corp. Sec. |
BUY
Grant, award, or other acquisition
|
Direct | 1,098 Added 0.82% |
-
|
Mar 27
2025 |
|
CPSI
|
Vita Mac Intyre
Controller |
SELL
Payment of exercise price or tax liability
|
Direct | 188 Reduced 7.19% |
$5,363
$28.53 p/Share
|
Mar 27
2025 |
|
HRL
|
Elsa A Murano |
SELL
Open market or private sale
|
Direct | 4,500 Reduced 4.5% |
$136,800
$30.4 p/Share
|
Mar 27
2025 |
|
CECE
|
Peter K. Johansson |
SELL
Open market or private sale
|
Direct | 5,601 Reduced 6.21% |
$135,264
$24.15 p/Share
|
Mar 27
2025 |
|
CIEN
|
Patrick Gallagher
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,738 Added 5.7% |
-
|
Mar 27
2025 |
|
CIEN
|
Joanne Beth Olsen
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,738 Added 9.8% |
-
|
Mar 27
2025 |
|
CIEN
|
Thomas Michael Nevens
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,738 Added 13.6% |
-
|
Mar 27
2025 |
|
CIEN
|
Devinder Kumar
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,738 Added 11.43% |
-
|
Mar 27
2025 |
|
HQL
|
Saba Capital Management, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 32,922 Reduced 0.0% |
$428,315
$13.01 p/Share
|
Mar 27
2025 |
|
GIM
|
Saba Capital Management, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 4,329 Reduced 0.0% |
$38,051
$8.79 p/Share
|
Mar 27
2025 |
|
CIEN
|
Hassan Ahmed
Director |
BUY
Grant, award, or other acquisition
|
Direct | 3,738 Added 13.76% |
-
|
Mar 27
2025 |
|
LH
|
Amy B. Summy
EVP, Chief Marketing Officer |
BUY
Grant, award, or other acquisition
|
Direct | 2,077 Added 23.88% |
-
|
Mar 27
2025 |
|
LH
|
Amy B. Summy
EVP, Chief Marketing Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 562 Reduced 8.49% |
$130,198
$231.67 p/Share
|
Mar 27
2025 |
|
LH
|
Vaart Sandra D Van Der
EVP, Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct | 3,325 Added 37.7% |
-
|
Mar 27
2025 |
|
LH
|
Vaart Sandra D Van Der
EVP, Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 1,352 Reduced 24.6% |
$313,217
$231.67 p/Share
|
Mar 27
2025 |
|
LH
|
Mark S Schroeder
EVP, Pres Diagnostics & COO |
BUY
Grant, award, or other acquisition
|
Direct | 4,840 Added 33.06% |
-
|
Mar 27
2025 |
|
LH
|
Mark S Schroeder
EVP, Pres Diagnostics & COO |
SELL
Payment of exercise price or tax liability
|
Direct | 2,205 Reduced 22.5% |
$510,832
$231.67 p/Share
|
Mar 27
2025 |
|
LH
|
Lance Berberian
EVP, Special Advisor, Strategy |
SELL
Payment of exercise price or tax liability
|
Direct | 1,353 Reduced 6.76% |
$313,449
$231.67 p/Share
|
Mar 27
2025 |